This modification led to significantly increased NK cell-mediated killing in a xenograft model using immunodeficient mice, confirming the crucial role of CHMP2A in modulating tumor sensitivity to NK cell cytotoxicity. This evidence concerns the gene CHMP2A and neoplasm.